Back |
home / stock / fcsc / fcsc message board
Subject | By | Source | When |
---|---|---|---|
O..ok gotcha. It's probably coming. | $avvyPenny$tockInvestorâ„¢ | investorshub | 04/16/2019 1:51:48 PM |
News yesterday... previous pr they released an 8k | Imarket13 | investorshub | 04/16/2019 1:49:01 PM |
8k on what? | $avvyPenny$tockInvestorâ„¢ | investorshub | 04/16/2019 1:48:08 PM |
They have yet to drop an 8k aswell | Imarket13 | investorshub | 04/16/2019 1:45:53 PM |
Right I agree. | $avvyPenny$tockInvestorâ„¢ | investorshub | 04/16/2019 1:39:20 PM |
If the company is diluting it's a damn | Imarket13 | investorshub | 04/16/2019 1:38:27 PM |
Me too. It's crazy. | $avvyPenny$tockInvestorâ„¢ | investorshub | 04/16/2019 1:36:35 PM |
Prob gonna ride out today and if still | Imarket13 | investorshub | 04/16/2019 1:35:20 PM |
reading a News is not enough-you have to | beambe | investorshub | 04/15/2019 9:13:28 PM |
Perfect bullshit-you've not understood the NEWS | beambe | investorshub | 04/15/2019 9:09:07 PM |
Got me some $2.50's on the dip today. | naturalborninvestor | investorshub | 04/15/2019 9:07:55 PM |
this will have Consequences | beambe | investorshub | 04/15/2019 8:50:19 PM |
News, Short Squeeze, Breakout and More Instantly...
Fibrocell Science Inc. Company Name:
FCSC Stock Symbol:
NASDAQ Market:
PARSIPPANY, N.J. , Sept. 12, 2019 /PRNewswire/ -- Castle Creek Pharmaceutical Holdings, Inc. ("CCP Holdings") today announced it has reached an agreement to acquire Fibrocell Science, Inc. (Nasdaq: FCSC), a cell and gene therapy company focused on transformational autologous cell-bas...
- Total consideration of $ 63.3 million, including repayment of debt and other financial instruments - - Acquisition expected to close in the fourth quarter of 2019 - - Further strengthens Castle Creek Pharmaceuticals as a leader in dermatology - EXTON, Pa., Sept. 12, 2019 (GL...
- Company to Host Conference Call and Webcast on Thursday, August 15 at 8:30 a.m. EDT - EXTON, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissu...